SCHEMBL27399335

SCHEMBL27399335

Cc1cnn(C)c1-c1c(N)c(C(N)=O)nc2cccnc12

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PRMT5 O14744 1/20 0.39
▸ CCNC P24863 1/20 0.37
▸ CDK8 P49336 1/20 0.37
▸ CDK19 Q9BWU1 1/20 0.37
▸ LMNA P02545 1/20 0.36
▸ PARP1 P09874 1/20 0.35
▸ LIMK1 P53667 1/20 0.34
▸ HRH4 Q9H3N8 1/20 0.34
▸ LCK P06239 2/20 0.33
▸ BTK Q06187 2/20 0.33
▸ SYK P43405 1/20 0.33
▸ PKMYT1 Q99640 2/20 0.33
▸ TLR8 Q9NR97 1/20 0.33
▸ KDM4E B2RXH2 1/20 0.33
▸ MBOAT4 Q96T53 1/20 0.32
▸ EPHB4 P54760 2/20 0.32
▸ CDK9 P50750 1/20 0.32
▸ DYRK1A Q13627 1/20 0.32
▸ DYRK1B Q9Y463 1/20 0.32
▸ AURKA O14965 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27400754 0.85 KDM4E (0.40) PRMT5CCNCCDK8CDK19LMNA
SCHEMBL27399933 0.79 PRMT5 (0.41) PRMT5LMNAPARP1LIMK1LCK
SCHEMBL27400870 0.79 SYK (0.36) PRMT5CCNCCDK8PARP1LIMK1
SCHEMBL27399014 0.78 LCK (0.51) PRMT5LMNAPARP1LIMK1LCK
SCHEMBL27399247 0.77 MKNK1 (0.50) PRMT5LMNAPARP1LIMK1LCK
SCHEMBL30905573 0.77 PKMYT1 (0.42) PRMT5LMNAPARP1PKMYT1KDM4E
SCHEMBL27397362 0.77 PKMYT1 (0.42) PRMT5LMNAPARP1PKMYT1KDM4E
SCHEMBL27398738 0.76 PARP1 (0.38) PRMT5LMNAPARP1LIMK1HRH4
SCHEMBL27399603 0.75 MKNK1 (0.40) PRMT5LMNAPARP1LIMK1LCK
SCHEMBL27399927 0.75 LIMK1 (0.37) PRMT5LMNAPARP1LIMK1PKMYT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024112853-A1 COMPOUNDS THAT INHIBIT PKMYT1 EXELIXIS, INC. (US) 2024-05-30 — — WO disclosed
Send feedback